Iterum Therapeutics plc (ITRMF)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Sep 8, 2026
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $53 as of October 9, 2026. It is the 53,049th most valuable company in the world and the 9,041st biggest in the United States. Its market cap has decreased by 100.00% in one year.
Market Cap
53.00
Enterprise Value
22.73M
Revenue
390.00K
Global Rank
Country Rank
#9,041 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from 179.38M to 53.00, a decrease of -100.00%. That is a compound annual growth rate of -83.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 53.00 | -100.00% |
| Dec 31, 2025 | 17.70M | -63.66% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RenovaCare | 87.00 |
| Cardax | 83.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |
| Core One Labs | 47.00 |